Cargando…

VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy

The absence of optimal treatments for Diabetic Nephropathy (DN) highlights the importance of the search for novel therapeutic targets. The vascular endothelial growth factor receptor 2 (VEGFR2) pathway is activated in experimental and human DN, but the effects of its blockade in experimental models...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavoz, Carolina, Rodrigues-Diez, Raul R., Plaza, Anita, Carpio, Daniel, Egido, Jesús, Ruiz-Ortega, Marta, Mezzano, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074274/ https://www.ncbi.nlm.nih.gov/pubmed/31973092 http://dx.doi.org/10.3390/jcm9020302

Ejemplares similares

Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis
por: Marquez-Exposito, Laura, et al.
Publicado: (2018)

Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process
por: Rodrigues Díez, Raúl, et al.
Publicado: (2010)

Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
por: Lavoz, Carolina, et al.
Publicado: (2012)

Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
por: Lavoz, Carolina, et al.
Publicado: (2020)

Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
por: Ruiz-Ortega, Marta, et al.
Publicado: (2020)

Gremlin Activates the Smad Pathway Linked to Epithelial Mesenchymal Transdifferentiation in Cultured Tubular Epithelial Cells
por: Rodrigues-Diez, Raquel, et al.
Publicado: (2014)

Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
por: Opazo-Ríos, Lucas, et al.
Publicado: (2020)

Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes
por: Opazo-Ríos, Lucas, et al.
Publicado: (2020)

Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
por: Opazo-Ríos, Lucas, et al.
Publicado: (2022)

Tubular Overexpression of Gremlin Induces Renal Damage Susceptibility in Mice
por: Droguett, Alejandra, et al.
Publicado: (2014)

Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension
por: Orejudo, Macarena, et al.
Publicado: (2019)

Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis
por: Droguett, Alejandra, et al.
Publicado: (2019)

TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2
por: Rodrigues-Díez, Raquel, et al.
Publicado: (2015)

Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
por: Opazo-Ríos, Lucas, et al.
Publicado: (2020)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

CCN2 Binds to Tubular Epithelial Cells in the Kidney
por: Rayego-Mateos, Sandra, et al.
Publicado: (2022)

Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
por: Huang, Hu, et al.
Publicado: (2011)

Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy
por: Deluque, Amanda Lima, et al.
Publicado: (2022)

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
por: Rayego-Mateos, Sandra, et al.
Publicado: (2020)

Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling
por: Rodrigues-Diez, Raquel, et al.
Publicado: (2016)

Blockade of VEGFR2 and Not VEGFR1 Can Limit Diet-Induced Fat Tissue Expansion: Role of Local versus Bone Marrow-Derived Endothelial Cells
por: Tam, Joshua, et al.
Publicado: (2009)

Potential of VEGFR2 expression as a predictive marker of PD-1 blockade in patients with advanced NSCLC
por: Kaira, Kyoichi, et al.
Publicado: (2022)

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

VEGFR-1 blockade disrupts peri-implantation decidual angiogenesis and macrophage recruitment
por: Douglas, Nataki C, et al.
Publicado: (2014)

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway
por: Civantos, Esther, et al.
Publicado: (2017)

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response
por: Zafarnia, Sara, et al.
Publicado: (2017)

Broussonin A– and B–mediated inhibition of angiogenesis by blockade of VEGFR‐2 signalling pathways and integrin β1 expression
por: Kim, Jae Hyeon, et al.
Publicado: (2022)

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2010)

Branched‐chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation
por: Zhenyukh, Olha, et al.
Publicado: (2018)

Blockade of myeloid differentiation protein 2 prevents obesity‐induced inflammation and nephropathy
por: Fang, Qilu, et al.
Publicado: (2017)

ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling
por: Su, Min, et al.
Publicado: (2016)

Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation
por: Esteban, Vanesa, et al.
Publicado: (2009)

TBX1 Represses Vegfr2 Gene Expression and Enhances the Cardiac Fate of VEGFR2+ Cells
por: Lania, Gabriella, et al.
Publicado: (2015)

VEGFR-2 reduces while combined VEGFR-2 and -3 signaling increases inflammation in apical periodontitis
por: Virtej, Anca, et al.
Publicado: (2016)

Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling
por: Ji, Chao, et al.
Publicado: (2016)

Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
por: Dieterich, Lothar C., et al.
Publicado: (2017)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

VEGFR2 alteration in Alzheimer’s disease
por: Cho, Sun-Jung, et al.
Publicado: (2017)

Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
por: Rusnati, Marco, et al.
Publicado: (2021)

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
por: Jinnin, Masatoshi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3road2hig8fom2pqjelleosta0